Ramsey Goodrich Elected to the Board of XPX
The Connecticut Chapter of the Exit Planning Exchange ("XPX"), is pleased to announce that Ramsey W. Goodrich, a Managing Director and Partner of Carter Morse & Mathias, was unanimously elected to the Board of Directors of XPX-CT.
Timing is everything ..... and now is the time!
Absent an extension by Congress, today's unusually favorable tax environment is scheduled to end December 31, 2012. Any business owner contemplating a sale in 2012 or 2013 needs to perform a detailed analysis and quantify how much money a few months of hesitation could cost. Given that the time required to successfully sell a business is generally between six and nine months, the next several weeks are a critical period for business owners.
Gary Mathias joins AICA Board of Directors
Carter Morse & Mathias is pleased to announce that Gary Mathias has been elected to the Board of Directors of the Alliance of International Corporate Advisors (AICA), a global network of investment banking firms.
CMM's Ramsey Goodrich receives ACG Meritorious Service Award
The Association for Corporate Growth® (ACG), the global organization focused on driving middle-market growth, announced that Ramsey Goodrich of Carter Morse & Mathias was selected as a 2012 Meritorious Service Award winner.
Healthcare industry leaders join Carter Morse & Goodrich Advisory Board
November 29, 2011
Carter Morse & Goodrich announced today the addition of Susan Davis president and chief executive officer of St. Vincent's Health Services, and Dr. Stephen Bloch, a general partner of Canaan Partners, to its Advisory Board.
Thetis Pharmaceuticals secures first round funding for diabetes drug
September 27, 2011
Thetis Pharmaceuticals LLC, a drug development company focused on diabetes, has secured first round funding from Connecticut Innovations and other institutional and angel investors.